SENSEX -667.29 -1.77%
36939.60
 
NIFTY -181.85 -1.64%
10891.60
 
Nasdaq 157.46 1.49%
10745.27
 
Nikkei 225 -629.23 -2.82%
21710.00
 
FTSE 100 -92.20 -1.54%
5897.80
 
YOU ARE ON
Equity
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
 
Sun Pharmaceutical Industries Ltd.
 
Source DateBoard Meeting DateDetails
27-Jul-2020 31-Jul-2020 Quarterly Results
18-May-2020 27-May-2020 Final Dividend & Audited Results
13-Mar-2020 17-Mar-2020 Buy Back of Shares inter alia, to consider and if deemed fit, to approve, inter alia, the proposal for buy-back of fully paid-up equity shares of the Company, which would include maximum amount, maximum number of equity shares, mode of buy-back and other matters incidental thereto in accordance with the provisions of Section 68, 69 and 70 of the Companies Act, 2013, read with rules made thereto and Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018.
03-Feb-2020 06-Feb-2020 Sub: Prior intimation under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 This is to inform you that the Board of Directors of the Company, at its meeting scheduled on Thursday, February 6, 2020, will inter-alia consider declaration of Interim Dividend on the equity shares of the Company, for the Financial Year 2019-2020.
17-Jan-2020 06-Feb-2020 Quarterly Results
23-Oct-2019 07-Nov-2019 Quarterly Results
29-Jul-2019 13-Aug-2019 Quarterly Results
10-May-2019 28-May-2019 Dividend inter alia, To consider recommendation of dividend for the year ended March 31 , 2019. & Audited Results
25-Jan-2019 12-Feb-2019 Quarterly Results
22-Oct-2018 13-Nov-2018 SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2018 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, November 13, 2018, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2018. In view of the above, the window closure for trading by designated persons as per Insider Trading Rules of the Company will be from Wednesday, October 31, 2018 to Thursday, November 15, 2018 (both days inclusive). This is for your information and record.
26-Jul-2018 14-Aug-2018 Quarterly Results
10-May-2018 25-May-2018 Dividend & Audited Results
29-Jan-2018 14-Feb-2018 Quarterly Results
30-Oct-2017 14-Nov-2017 1. This is to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, November 14, 2017 to consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2017. 2. In view of the consideration of above, the window closure for trading by designated persons as per Insider Trading Rules of the Company will be from Friday, November 3, 2017 to Thursday, November 16, 2017 (both days inclusive).
26-Jul-2017 11-Aug-2017 Dear Sirs, 1. This is to inform you that a meeting of the Board of Directors of the Company will be held on Friday, August 11, 2017 to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2017. 2. In view of the consideration of above, the window closure for trading by designated persons as per Insider Trading Rules of the Company will be from Wednesday, August 2, 2017 to Wednesday, August 16, 2017 (both days inclusive). This is for your information and record.
11-May-2017 26-May-2017 Sun Pharmaceutical Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 26, 2017, inter alia, to transact the following business: 1. To consider and approve standalone and consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2017. 2. To consider recommendation of dividend for the year ended March 31, 2017 subject to the approval of the shareholders at the ensuing Annual General Meeting. Further, the window closure for trading by designated persons as per Insider Trading Rules of the Company will be from May 17, 2017 to May 30, 2017 (both days inclusive). & Dividend & Audited Results
31-Jan-2017 14-Feb-2017 Quarterly Results
25-Oct-2016 10-Nov-2016 Sun Pharmaceutical Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 10, 2016, inter alia, to transact the following business: 1. To consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2016 (Q2). 2. To consider the proposal for the merger/amalgamation of Ranbaxy Drugs Limited, Vidyut Investments Limited, Gufic Pharma Limited and Sun Pharma Medisales Private Limited (formerly known as Solrex Pharmaceutical Company), all four companies being wholly owned subsidiaries of Sun Pharmaceutical Industries Ltd., with Sun Pharmaceutical Industries Ltd subject to receipt of necessary approvals. & Quarterly Results
02-Aug-2016 12-Aug-2016 Quarterly Results
16-May-2016 30-May-2016 Audited Results & Dividend
Page 1 of 5
Prev || Next
ADINATH STOCK BROKING PVT LTD  :   SEBI REGISTRATION NUMBERS : Bombay Stock Exchange(BSE): CASH -INB011280535 & DERIVATIVE -INF011280535 Member ID-3175 National Stock Exchange(NSE): CASH- INB231280539 & DERIVATIVES -INF 231280539 Member ID-12805 MCX-SX Stock Exchange(MCX-SX): Currency Derivative : INE261280535 Member ID-44400 United Stock Exchange(USE): Currency Derivative: Central Depository Services Ltd(CDSL)- IN -DP-452/2008 DP ID :- 12055200
ADINATH COMMODITIES  :   COMMODITIES FMC REGISTRATION NUMBERS : MultiCommodity Exchange Ltd (MCX): MCX/TCM/PART/0427 Member ID -10140 National Commodity and Derivatives Exchange Ltd (NCDEX):NCDEX/TCM/PART/0426 Member ID -00622.
ATTENTION INVESTORS :   "Prevent unauthorised transactions in your Broking & demat account--> Update your mobile numbers/email IDs with your stock brokers & depository participate. Receive information of your transactions directly from Exchange & CDSL on your mobile/email at the end of the day......................Issued in the interest of Investors"
ATTENTION INVESTORS :   "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
ATTENTION INVESTORS :   "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
| Disclaimer | Privacy Policy | Feedback | Terms and Conditions | Careers | Investor Grievances | Download | Investor Protection | SCORES | Site Map
Useful links: NSE | BSE | MCX-SX | CDSL | SEBI | MCX | NCDEX | FMC
Copyright © 2011 Adinath Stock Broking Pvt Ltd                             Designed, Developed & Content Powered By Accord Fintech Pvt.Ltd.